Stockreport

Regenxbio Inc (RGNX) Q3 2024 Earnings Call Highlights: Advancements in Gene Therapy and ... [Yahoo! Finance]

REGENXBIO Inc.  (RGNX) 
Last regenxbio inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.regenxbio.com
PDF R&D Expenses: $54 million for Q3 2024, compared to $58 million for Q3 2023. Net Proceeds from Public Offering: $131 million received from an upsized public offering i [Read more]